Graham Capital Management’s Cerence CRNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-47,347
Closed -$506K 1224
2025
Q4
$506K Buy
+47,347
New +$520K 0.01% 622
2025
Q3
Sell
-16,067
Closed -$164K 1314
2025
Q2
$164K Buy
+16,067
New +$141K ﹤0.01% 1158
2024
Q4
Sell
-80,597
Closed -$254K 1273
2024
Q3
$254K Sell
80,597
-124
-0.2% -$365 ﹤0.01% 844
2024
Q2
$228K Buy
+80,721
New +$575K 0.01% 819
2024
Q1
Sell
-22,419
Closed -$441K 1102
2023
Q4
$441K Buy
+22,419
New +$389K 0.01% 629
2023
Q1
Sell
-82,761
Closed -$1.53M 1099
2022
Q4
$1.53M Buy
82,761
+55,559
+204% +$952K 0.05% 378
2022
Q3
$428K Buy
+27,202
New +$611K 0.02% 796

Other funds holding CRNC

Graham Capital Management's CRNC Position: Q1 2026 in Review

Graham Capital Management sold out of Cerence (CRNC) in Q1 2026, closing a stake of 47,347 shares — an estimated $506K sold.

Graham Capital Management first reported a position in CRNC in Q3 2022 and held it in 7 quarters. The position peaked at $1.53M in Q4 2022. 195 funds tracked by Wall St. Rank hold CRNC as of Q1 2026.

  • Graham Capital Management reported no remaining Cerence position as of Q1 2026 after selling out during the quarter.
  • Graham Capital Management sold 47,347 Cerence shares in Q1 2026, an estimated $506K.
  • Graham Capital Management first reported a position in Cerence in Q3 2022 and held it in 7 quarters.
  • Graham Capital Management's Cerence position peaked at $1.53M in Q4 2022.
  • 195 funds tracked by Wall St. Rank held Cerence as of Q1 2026.

Based on Graham Capital Management's 13F filing for Q1 2026, filed 15 May 2026.